Cyteir: Although The Company Is Winding Down, The Lead Asset Had Promise (NASDAQ:CYT)

closed business with closed placard on roller shutter metal

Cunaplus_M.Faba/iStock via Getty Images

Cyteir (NASDAQ:CYT) is a developer of cancer therapeutics. Lead candidate CYT-0851 is an orally bioavailable small molecule inhibitor of monocarboxylate transporters targeting relapses or refractory solid tumors in a phase 1 trial. In July, despite seeing drug

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *